NVASC

Serial Number 98812225
686

Registration Progress

Application Filed
Oct 21, 2024
Under Examination
Approved for Publication
Jun 3, 2025
Published for Opposition
Jun 3, 2025
Registered

Trademark Image

NVASC

Basic Information

Serial Number
98812225
Filing Date
October 21, 2024
Published for Opposition
June 3, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Oct 14, 2025
Application
Pending
Classes
042

Rights Holder

NVasc, Inc.

03
Address
77 Magnolia Drive
Atherton, CA 94027

Ownership History

NVasc, Inc.

Original Applicant
03
Atherton, CA

NVasc, Inc.

Owner at Publication
03
Atherton, CA

Legal Representation

Attorney
Christiane S. Campbell

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Nov 4, 2025 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Nov 3, 2025 APET A ASSIGNED TO PETITION STAFF Loading...
Oct 12, 2025 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Sep 24, 2025 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Sep 15, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 15, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 15, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 2, 2025 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jun 3, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 3, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 28, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 1, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 24, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 23, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development relating to pharmaceuticals and biologics for the treatment of ophthalmological diseases and disorders; research and development relating to pharmaceuticals and biologics for the treatment of neurological, cerebrovascular and vascular diseases and disorders; conducting evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation

Additional Information

Pseudo Mark
N VASC

Classification

International Classes
042